Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
MRNA Coverage
Transcript
Moderna, Inc (MRNA) Q4 2025 Earnings Call Transcript
Mar 10, 2026
Event
Moderna, Inc (MRNA) Sec Form 8K
Mar 6, 2026
Event
Moderna, Inc (MRNA) Moderna Resolves Global Patent Litigation with Arbutus/Genevant
Mar 3, 2026
Event
Moderna, Inc (MRNA) European Medicines Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19
Feb 27, 2026
News
Moderna Q4 2025 net loss narrows; revenue drops 30%
Feb 16, 2026
News
Moderna Reports 4Q Revenue Of $678 Million, Projects 2026 Growth
Feb 13, 2026
Transcript
Moderna, Inc (MRNA) Q2 2022 Earnings Call Transcript
Jan 27, 2026
Transcript
Moderna, Inc (MRNA) Q2 2025 Earnings Call Transcript
Jan 22, 2026